DCF — ATLANTA MEDICAL CENTER
Enterprise Value: $-186.6M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-186.6M
Enterprise Value
$-57.9M
PV of Cash Flows
$-128.7M
PV of Terminal Value
$-207.3M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $83.4M | $-12.2M | -15.0% | $-15.8M | $-14.3M |
| Year 2 | $85.9M | $-11.7M | -14.0% | $-15.4M | $-12.7M |
| Year 3 | $88.5M | $-11.2M | -13.0% | $-15.0M | $-11.2M |
| Year 4 | $91.2M | $-11.1M | -12.0% | $-15.0M | $-10.2M |
| Year 5 | $93.9M | $-11.2M | -12.0% | $-15.2M | $-9.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-186.6M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$81.0M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.15168279838225138
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5